Related Experiment Videos
Collaborative care for alcohol-related liver disease
Kieran J Moriarty1, Helen Platt, Sandra Crompton
1Royal Bolton Hospital, Bolton. kieran.moriarty@rbh.nhs.uk
Clinical Medicine (London, England)
|May 12, 2007
Summary
Implementing collaborative care for patients with alcohol misuse and alcohol-related liver disease significantly improved care coordination and patient outcomes. This approach enhanced staff and patient satisfaction, communication, and treatment accuracy.
Area of Science:
- Medicine
- Public Health
- Psychiatry
Background:
- Alcohol misuse and alcohol-related liver disease present significant public health challenges.
- Fragmented care pathways often hinder effective management for these patients.
- Coordinated, multidisciplinary approaches are needed to address complex patient needs.
Purpose of the Study:
- To evaluate the impact of implementing a collaborative care model for patients with alcohol misuse and alcohol-related liver disease.
- To improve the coordination and quality of care provided to this patient population.
- To assess changes in patient and staff attitudes, satisfaction, and treatment outcomes.
Main Methods:
- Recruitment of a multidisciplinary team focused on patient-centered care.
- Integration of gastroenterology and psychiatry expertise within a joint team structure.
- Systematic tracking of drinking histories, detoxification, and dietary documentation.
Main Results:
- Marked improvement in the accuracy of drinking histories and dietary documentation.
- Enhanced patient and staff attitudes, confidence, and satisfaction.
- Increased inpatient and outpatient referrals, indicating improved accessibility and communication.
Conclusions:
- Collaborative care models are effective in improving the management of alcohol misuse and related liver disease.
- Joint gastroenterology/psychiatry teams enhance care coordination and patient outcomes.
- There is a critical need for national steering groups and dedicated alcohol health workers to combat rising alcohol misuse.
Related Concept Videos
Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Chronic Kidney Disease III: Interprofessional Care
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...